Belgia -
angielski -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
magnesium sulfate sterop 1 g/2 ml inf. sol. (conc.) i.v. amp.
laboratoires sterop sa-nv - magnesium sulfate heptahydrate 500 mg/ml - eq. magnesium 49,35 mg/ml - concentrate for solution for infusion - 500 mg/ml - magnesium sulfate heptahydrate 500 mg/ml - magnesium sulfate
Belgia -
angielski -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
magnesium sulfate sterop 2 g/10 ml inf. sol. (conc.) i.v. amp.
laboratoires sterop sa-nv - magnesium sulfate heptahydrate 2 g/10 ml - concentrate for solution for infusion - 2 g/10 ml - magnesium sulfate heptahydrate 200 mg/ml - magnesium sulfate
Belgia -
angielski -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
magnesium sulfate sterop 2,5 g/5 ml inf. sol. (conc.) i.v. amp.
laboratoires sterop sa-nv - magnesium sulfate heptahydrate 500 mg/ml - eq. magnesium 49,35 mg/ml - concentrate for solution for infusion - 500 mg/ml - magnesium sulfate heptahydrate 500 mg/ml - magnesium sulfate
Belgia -
angielski -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
magnesium sulfate sterop 1,5 g/5 ml inf. sol. (conc.) i.v. amp.
laboratoires sterop sa-nv - magnesium sulfate heptahydrate 300 mg/ml - eq. magnesium 29,58 mg/ml - concentrate for solution for infusion - 300 mg/ml - magnesium sulfate heptahydrate 300 mg/ml - magnesium sulfate
Belgia -
angielski -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
magnesium sulfate sterop 1 g/10 ml inj. sol. i.v. amp.
laboratoires sterop sa-nv - magnesium sulfate heptahydrate 100 mg/ml - eq. magnesium 9,87 mg/ml - solution for injection - 1 g/10 ml - magnesium sulfate heptahydrate 100 mg/ml - magnesium sulfate
Izrael -
angielski -
Ministry of Health
magnesium sulfate 50 % wv inovamed
inovamed ltd - magnesium sulfate as heptahydrate - solution for injection / concentrate for solution for inj/inf - magnesium sulfate as heptahydrate 500 mg / 1 ml - magnesium sulfate - magnesium sulfate 50%w/v inovamed is indicated for:1. the treatment of magnesium deficiency in hypomagnesaemia. 2. the prevention and treatment of hypomagnesaemia in patients receiving total parenteral nutrition. 3. the control and prevention of seizures in severe pre-eclampsia. 4. the control and prevention of recurrent seizures in eclampsia
Izrael -
angielski -
Ministry of Health
magnesium sulfate kalceks 50 %
a.l. medi-market ltd. - magnesium sulfate heptahydrate - solution for injection / concentrate for solution for inj/inf - magnesium sulfate heptahydrate 500 mg / 1 ml - magnesium sulfate - magnesium sulfate kalceks 50% solution for injection or infusion is indicated for: the treatment of magnesium deficiency in hypomagnesaemiathe prevention and treatment of hypomagnesaemia in patients receiving total parenteral nutritionthe control and prevention of seizures in severe pre-eclampsiathe control and prevention of recurrent seizures in eclampsia
Irlandia -
angielski -
HPRA (Health Products Regulatory Authority)
magnesium verla 5 mmol granules for oral solution
rowa pharmaceuticals limited - magnesium - granules for oral solution - 5 millimole(s) - magnesium aspartate
Australia -
angielski -
Department of Health (Therapeutic Goods Administration)
magnesium max
pharmametics products a division of max biocare pty ltd - calcium hydrogen phosphate dihydrate,magnesium amino acid chelate,magnesium citrate,magnesium orotate,taurine,viburnum opulus -
Wielka Brytania -
angielski -
MHRA (Medicines & Healthcare Products Regulatory Agency)
neomag (magnesium 97mg (4mmol)) chewable tablets
magnesium 97mg (4mmol)) chewable tablets (neoceuticals ltd - magnesium glycerophosphate - chewable tablet - 97.2mg